ESC 2022 Late-breaker Discussion: The INVICTUS Trial
Автор: Radcliffe Cardiology
Загружено: 2022-08-28
Просмотров: 1600
Описание:
Watch on Radcliffe Cardiology: https://www.aerjournal.com/video-inde...
Late-breaker host, Dr Harriette Van Spall(McMaster University, CA) invited Dr Ganesan Karthikeyan (All India Institute of Medical Sciences, IN) to share the latest data from the INVICTUS trial (NCT02832544).
This randomized, open-label, non-inferiority trial compared rivaroxaban (Xarelto, Bayer) versus standard vitamin K antagonists (VKA) (Warfarin) therapy in 4,500 patients diagnosed with rheumatic heart disease.
Recorded on-site at ESC Congress 2022, Barcelona.
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
![La SEC te lleva a ESC22 [IN] - INVICTUS Trial](https://ricktube.ru/thumbnail/6OdBHLGNjEQ/mqdefault.jpg)
